Study Suggests Estrogen Deficiency Can Lead To Obesity-InducedAugust 09, 2007Austin, TX - At menopause, women lose hormone protection against heart (cardiovascular) and kidney (renal) diseases, and are likely to become obese. A research team has tested the idea that estrogen deficiency in aged females may trigger the development of high blood pressure and obesity. The results of their study, using an animal model, suggest that estrogen depletion can have these effects. The study is entitled, "Role of Estrogens in Postmenopausal Obesity and Hypertension." It was conducted by Lourdes A. Fortepiani and Huimin Zhang, University of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio, TX. The team will discuss its findings as part of the upcoming conference, Sex and Gender in Cardiovascular-Renal Physiology and Pathophysiology, being held August 9-12, 2007 at the Hyatt Regency Austin on Town Lake in Austin, TX. The event is the second scientific gathering to be sponsored by the American Physiological Society (APS; www.The-APS.org) this year. To test their theory the researchers used 24 aged female rats. The ovaries were removed from two-thirds of the group (ovariectomized; ovx) while the ovaries of the other third of the group remained intact and served as controls. The researchers subdivided the ovx rats, giving half of the ovx group estrogen while the other half remained estrogen depleted.
Among the ovx rats, those that did not receive estrogen had significantly higher blood pressure than the control rats (126.2 versus 110.6 mmHg). The rats receiving estrogen had the lowest blood pressure levels of all (102.6 mmHg). The researchers also noted that the rats which had their ovaries removed and did not receive estrogen compared to the intact rats * gained twice as much weight as the controls * increased their leptin level by 70 percent * increased their blood glucose level by 35 percent * increased RAS and renal SNS by 16 and 39 percent * experienced no change in kidney function All the hormonal and metabolic effects were completely abolished with estrogen replacement. In other words, the rats whose ovaries were removed and received estrogen replacement did not undergo any of the changes mentioned above. With increased life expectancy, women spend more than a third of their life in menopause. In addition, obesity is increasing dramatically in all populations and is a major cardiovascular risk factor in women after menopause. Despite the controversial data about estrogen therapy in clinical studies, the results of this study performed in aged rats suggest that the loss of estrogens after menopause may contribute to the development of obesity and hypertension, opening new therapeutic approaches to postmenopausal hypertension. American Physiological Society | |||||||||||||||||||||
|
Related Estrogen Current Events and Estrogen News Articles Study identifies causes of bone loss in breast cancer survivors Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss. Migraines associated with lower risk of breast cancer Women who suffer from migraines may take at least some comfort in a recent, first-of-its-kind study that suggests a history of such headaches is associated with a significantly lower risk of breast cancer. Scientists identify new gene responsible for puberty disorders A new gene responsible for some puberty disorders has been identified by Medical College of Georgia researchers. Birth control has long-term effect on hormone exposure Researchers at Wake Forest University School of Medicine may be one step closer to understanding why past oral contraceptive use dramatically lowers the risk of ovarian and uterine cancers later in life. Clue to genetic cause of fatal birth defect A novel enzyme may play a major role in anencephaly, offering hope for a genetic test or even therapy for the rare fatal birth defect in which the brain fails to develop, according to a study from researchers at the University of Illinois at Chicago College of Medicine. Bisphenol A linked to chemotherapy resistance Exposure to bisphenol A (BPA) may reduce the effectiveness of chemotherapy treatments, say University of Cincinnati (UC) scientists. Tamoxifen chemoprevention tied to early detection of breast cancer The drug tamoxifen does not prevent or treat estrogen receptor (ER) negative breast cancer, but it can make the disease easier to find, researchers report in the Oct. 1 Journal of the National Cancer Institute. Herbal Menopause Therapy a Good Fit for Breast Cancer Patients? When it comes to understanding the effectiveness and safety of using herbal therapies with other drugs, much is unknown. Now, a University of Missouri researcher will study how black cohosh - an herbal supplement often used to relieve hot flashes in menopausal women - interacts with tamoxifen, a common drug used to treat breast cancer. 6 environmental research studies reveal critical health risks from plastic Exposure to Bisphenol A (BPA), phthalates and flame retardants (PBDEs) are strongly associated with adverse health effects on humans and laboratory animals. New predictive tool can help determine treatment of breast cancer patients A new predictive measurement, called a PEPI score, could bring good news to many women diagnosed with early stage breast cancer - a low PEPI (preoperative endocrine prognostic index) score could show that they have little risk of relapse and can safely avoid chemotherapy after surgery. More Estrogen Current Events and Estrogen News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||